Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Trial-Reported Endpoints by Phase Trial Lancet 2021 Phase 2 Duration 26 weeks Population Overweight/obese, no T2D (n=706) Mean Weight Loss 10.8% at 4.5 mg vs 3.0% placebo Trial Lancet 2023 Phase 2 Duration 32 weeks Population T2D + obesity (n=92) Mean Weight Loss 8.1% cagrilintide alone
This lyophilized peptide blend is supplied in a sterile, sealed vial format intended to support laboratory handling, controlled storage, and preparation according to institutional protocols
Oral bioavailability is estimated at approximately 38%
doi: 10.1016/j.jep.2010.06.009, 39
US$ 27.43
US$ 27.00
US$ 28.71
